Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-dail (Q57212874)
Jump to navigation
Jump to search
scholarly article by Weiping Jia et al published April 2015 in The Lancet: Diabetes & Endocrinology
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-dail |
scholarly article by Weiping Jia et al published April 2015 in The Lancet: Diabetes & Endocrinology |
Statements
Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-dail (English)
0 references
Lee-Ming Chuang
1 reference
April 2015
0 references
3
0 references
4
0 references
254-62
0 references
254-262
0 references